Fundz

EnVision Endoscopy has closed an oversubscribed $11.5 million Series A financing. This funding will support the company's transition to clinical adoption of its SimpleStitch™ Suturing System.

PRIVATENov 10, 2026

Amount Raised

$11.5 Million

Round Type

Series A

WalthamBiotechnologyHealth CareMedicalMedical Device

Description

EnVision Endoscopy, Inc. announced the successful closing of an oversubscribed $11.5 million Series A financing. The funds will enable the company to further its clinical adoption and commercial expansion efforts. This funding marks a shift in the company's journey from technology development to practical application

Who to call at EnVision Endoscopy, and when

A new round usually means EnVision Endoscopy is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day EnVision Endoscopy raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at EnVision Endoscopy, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at EnVision Endoscopy. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

EnVision Endoscopy

Location

Waltham, Massachusetts, United States

About

EnVision Endoscopy, Inc. is a medical technology company focused on developing innovative solutions for gastrointestinal endoscopic surgery. The company aims to simplify endoscopic suturing and make it more accessible to physicians. Their SimpleStitch™ Suturing System is designed for use with standard flexible endoscopes and addresses challenges associated with tissue closure in advanced procedures. EnVision received FDA clearance for this technology and is committed to expanding its clinical adoption and commercial presence.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment EnVision Endoscopy raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for EnVision Endoscopy's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

EnVision Endoscopy raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.